ICE
49
-4
AFL
48
3
NTRS
52
-12
SYY
52
2
SNA
55
-13
MLM
58
4
VIX
46
2
BMY
37
-4
EFX
52
2
FOXA
64
-2
APD
54
2
MSFT
61
10
SHW
53
-5
LOW
36
2
CRM
49
4
HAL
46
-4
DD
60
3
CHRW
48
-2
AME
47
-6
KHC
36
-2
ICE
49
-4
AFL
48
3
NTRS
52
-12
SYY
52
2
SNA
55
-13
MLM
58
4
VIX
46
2
BMY
37
-4
EFX
52
2
FOXA
64
-2
APD
54
2
MSFT
61
10
SHW
53
-5
LOW
36
2
CRM
49
4
HAL
46
-4
DD
60
3
CHRW
48
-2
AME
47
-6
KHC
36
-2
Financhill
Back

Corcept Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
56

CORT
Corcept Therapeutics

Last Price:
$70.87
Seasonality Move:
7.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Corcept Therapeutics Stock Forecast

  • Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 32.1% based on the past 21 years of stock performance.
  • Corcept Therapeutics has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%
  • Is Corcept Therapeutics Stock Undervalued?
    The current Corcept Therapeutics [CORT] share price is $70.86. The Score for CORT is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • CORT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Corcept Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Corcept Therapeutics has on average historically risen by 32.1% based on the past 21 years of stock performance.

Corcept Therapeutics Stock Rating

Buy
56
Corcept Therapeutics (CORT) is a Buy

Is Corcept Therapeutics overpriced?

  • Corcept Therapeutics has risen higher in 13 of those 21 years over the subsequent 52-week period, corresponding to a historical accuracy of 61.9%

Corcept Therapeutics Stock Price History

Is CORT stock going to rise?

  • The current trend is moderately bearish and CORT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
corcept.com

52-Week Data

52-Week High:
117.33
52-Week Low:
32.33

Prediction Charts

Market Cap:
7.5B
Price in USD:
70.86
Volume:
563.1K
Beta:
0.77

Technical Analysis

SMA50:
72.52
SMA100:
69.19
SMA200:
62.18
52-Wk Change:
112.86%

Stock Predictions

  • Is Corcept Therapeutics stock public?
    Yes, Corcept Therapeutics is a publicly traded company.
  • What is the Corcept Therapeutics stock quote today?
    The Corcept Therapeutics stock price is 70.86 USD today.
  • How to buy Corcept Therapeutics stock online?
    You can buy Corcept Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-30 73.60 73.40 73.81 71.74
Jul-1 73.30 69.31 73.80 69.28
Jul-2 69.12 71.34 71.57 68.52
Jul-3 71.63 72.27 72.72 71.45
Jul-7 71.54 67.55 71.55 66.49
Jul-8 67.54 68.16 68.55 67.38
Jul-9 68.98 70.89 70.94 68.32
Jul-10 71.08 72.01 72.49 70.16
Jul-11 72.01 71.88 72.23 70.09
Jul-14 71.85 72.77 73.44 71.54
Jul-15 72.66 71.41 72.66 70.14
Jul-16 71.66 72.85 73.46 71.54
Jul-17 72.85 73.10 73.78 72.41
Jul-18 73.49 70.86 73.50 70.76

Corcept Therapeutics Earnings

Corcept Therapeutics Earnings Report: Per Share Corcept Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Corcept Therapeutics Forecast Revenue Growth

Corcept Therapeutics Stock Analysis: Historical quarterly revenues per share for Corcept Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.03 per share, and an increase next year of $1.28 per share.

* Corcept Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.